Peter Maag

Peter Maag is an experienced executive and board member with a diverse background in the healthcare and pharmaceuticals sectors. Currently serving as Director at BluLake Ventures and as a board member for multiple organizations including PHOENIX group, CareDx, Inc., and Miromatrix, Maag has held significant leadership roles at Kyverna Therapeutics and Novartis, notably overseeing diagnostics and specialty pharmaceuticals. Maag's career includes a successful tenure at McKinsey & Co, where contributions were made across various industries with a focus on healthcare. Academically, Maag holds a PhD in Healthcare from Humboldt-Universität zu Berlin, a Master's degree in Pharmacy from Heidelberg University, and a Master's from The School of Pharmacy, University of London.